Cargando…
Antioxidants as Therapeutic Agents in Acute Respiratory Distress Syndrome (ARDS) Treatment—From Mice to Men
Acute respiratory distress syndrome (ARDS) is a major cause of patient mortality in intensive care units (ICUs) worldwide. Considering that no causative treatment but only symptomatic care is available, it is obvious that there is a high unmet medical need for a new therapeutic concept. One reason f...
Autores principales: | von Knethen, Andreas, Heinicke, Ulrike, Laux, Volker, Parnham, Michael J., Steinbicker, Andrea U., Zacharowski, Kai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773193/ https://www.ncbi.nlm.nih.gov/pubmed/35052778 http://dx.doi.org/10.3390/biomedicines10010098 |
Ejemplares similares
-
Nrf2—A Molecular Target for Sepsis Patients in Critical Care
por: Gunne, Sandra, et al.
Publicado: (2020) -
Histone Deacetylation Inhibitors as Modulators of Regulatory T Cells
por: von Knethen, Andreas, et al.
Publicado: (2020) -
Angiotensin II treatment in COVID-19 patients: more risk than benefit? A single-center experience
por: Heinicke, Ulrike, et al.
Publicado: (2020) -
Persistently Elevated Plasma Concentrations of RIPK3, MLKL, HMGB1, and RIPK1 in Patients with COVID-19 in the Intensive Care Unit
por: Ruskowski, Katharina, et al.
Publicado: (2022) -
Measles-induced respiratory distress, air-leak and ARDS
por: Piastra, M., et al.
Publicado: (2009)